Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyze and structure the next financing round. Venture Valuation has to, given a very tight deadline, customize the evaluation process to using quantitative and qualitative data to best meet its customers needs. The case outlines the task ahead of Venture Valuation and requires students to make assessments and calculations and finally come up with a valuation for the startup, Genedata.
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications